Translating science into sustainable solutions

Core technology is the foundation of a wide range of innovative applied products

SGI and its business units have developed key partnerships and agreements with multiple industry leaders. For more information about our business and how to partner with us, please contact our Corporate Development team at

Applied products

Creating novel solutions and transforming existing products


Flu Vaccines, Gene/Cell Therapy, Biologics, Organ Transplants, Antimicrobials


Dietary Supplements, Food Ingredients, Omega 3 Oils, Algal Protein


Renewable Chemicals, Bio-based Intermediates, Plant Enhancement and Protection, Algal Biofuel


Current Partnered Programs


Non-GMO algal omega-3 DHA

Developing products containing Omega-3 Docosahexaenoic Acid (DHA) from a non-genetically modified algae strain.

Read Case Study


Algal biofuel

SGI and ExxonMobil are focused on researching and developing naturally occurring and conventionally modified algae strains for use in developing algae-based biofuels.

Read Case Study


Multivalent RNA-based vaccines

SGI, JCVI and GSK are collaborating to develop and evaluate multivalent RNA-based vaccines for protection against a highly diverse infectious disease pathogen.


Rapid precision flu vaccine

SGI employed synthetic genomics tools and technologies developed by our team to accelerate the production of the influenza vaccine seeds required for vaccine manufacturing.

Read Case Study

United Therapeutics

Mammalian cell engineering

SGI and United Therapeutics have joined together to address the critical unmet organ need through xenotransplantation, the use of pigs as an essentially unlimited source of donor organs.

Read Case Study


Future Applications

Direct market and strategic partnership opportunities

Life Science Instruments
Nutritional Protein
Cell Therapy